Paula Annunziato, MD, Vice President and Therapeutic Head, Vaccines Clinical Research, Merck

Vaccine Development - A Multi-Disciplinary Commitment to Protect Public Health

Samir M. Hanash, MD, PhD, Professor, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center

Mining the Proteometabolome for Precision Medicine

Nina Isoherranen, PhD, Professor, Vice Chair, Pharmaceutics, Department of Pharmaceutics, University of Washington

Predicting in vivo Drug–Drug Interactions Involving Multiple Precipitants

Irina Koroleva, PhD, Director, Translational Medicine, Rubius Therapeutics

Translational Medicine in the Era of Cellular Therapies: Challenges and Opportunities in Developing PK Bioanalytical Method(s)

Patrick Combes, Amazon Web Services Worldwide Technical Leader - Healthcare and Life Sciences

Biopharma-Industry Compliance in the Cloud

Phillip Sundman, Director PDM Bioinformatics and System Validation at Pfizer

Approaches and Considerations for Utilizing the Cloud for Cost Effective Instrument Data Storage

Sanne Demandt, PhD, Group Leader, Charles River Laboratories, Leiden

Advances and Challenges for T Cell Therapies

Prashant Desai, PhD, Research Advisor and Group Leader, Computational ADME, Eli Lilly and Company

Realistic Application of Machine Learning ADME Models to Impact Drug Discovery

Rob Foti, PhD, Principal Scientist, Amgen

Navigating ADME Challenges with Non-Opioid Based Pain Therapeutics

Kaushik Mitra, Director, Molecular and Investigative Toxicology, Merck

An Integrated Strategy Utilizing Transcriptional Profiling to De-Risk Bioactivation-Mediated Drug-Induced Liver Injury

Jaya Goyal, PhD, Vice President, Bioanalytical, Pharmacology and Biomarker Development, Wave Life Sciences, Ltd.

Combinatorial Approaches for Bioanalysis of Stereopure Oligonucleotides

Klarissa Jackson, PhD, Professor, University of North Carolina Chapel Hill Eshelman School of Pharmacy

Metabolic Activation of Tyrosine Kinase Inhibitors by Cytochromes P450: Impact of Interindividual Variation

Hyunyoung (Young) Jeong, PharmD, PhD, Professor, College of Pharmacy, University of Illinois at Chicago

Gut Microbiota Modulates Acetaminophen-Induced Hepatic Injury

Liang Jin, PhD, Senior Scientist, DMPK, AbbVie Bioresearch Center

Improve Target Discovery from Label-Free Proteomic Data by Machine Learning Algorithms

Colleen Kelly, MD, FACG, Associate Professor of Medicine, Warren Alpert Medical School of Brown University

Update on Fecal Microbiota Transplantation: Indications, Methodologies, Mechanisms and Future Perspective

Dan Kim, M.S., Senior Scientist, DMPK, AbbVie

Development and Application of LC/MS BA Platform for Biologics

Priyanka Kulkarni, PhD, Scientist, Pharmacokinetics and Drug Metabolism, Amgen

Modeling and Simulation to Study the Impact of Transporter-Enzyme Interplay on Drug-Drug Interactions

Mike Lee, PhD, Founder and President, Milestone Development Services

Failure is an Option if You Keep Trying...

Mark Milton, PhD, Executive Director, PK Sciences - Global Head Opthamology TA, Novartis Institutes for Biomedical Research

The Development of Viral Vector-Based Gene Therapies: It's Not What You Do But the Way That You Do It.

Russell Mortishire-Smith, PhD, Senior Consulting Scientist, Applied Informatics, Scientific Operations, Waters Corporation

Approaches to Real Time Prediction of Collision Cross Section Values

Heather Myler, PhD, Director, Bioanalytical Laboratories, PPD

ADA Validation Testing and Reporting Global Harmonization

Lisa O'Callaghan, PhD, Associate Principal Scientist, PPDM, Merck

Method Improvements for Discovery Monoclonal Antibody Pharmacokinetics

Mireia Fernandez Ocana, PhD, Biomarker Discovery Lead, Pfizer

Immunoaffinity LC-MS/MS Technologies for Translational Safety Biomarker Development

Leila Pirhaji, PhD, Founder and CEO, ReviveMed

Translating Metabolomics into Therapeutics Insights using Artificial Intelligence

Terry Podoll, PhD, Principal Consultant, IV/PO LLC

Acalabrutinib Bioavailability, Biotransformation, and Excretion using a Microtracer and Tang, the Human ADME Formulation Every Mother Trusts

Brooke Rock, PhD, Principal Scientist, Pharmacokinetics and Drug Metabolism, Amgen

Transforming Traditional SM ADME Assays to Support the Translation of siRNA Pharmacology from the Benchtop to the Clinic

Magdalena Tary-Lehmann, MD, PhD, Co-Founding Scientist and CSO, Cellular Technology Limited

Immunogenicity Assessment in Support of Gene Therapy Program-Use of ELISPOT Technology

Yu Tian, PhD, Director, Non-Regulated Bioanalysis Department, AbbVie Bioresearch Center

An Integrative Proteogenomics Pipeline Identifying Differentially Expressed Splicing Variants from IDB Patients

Esther van Duijn, PhD, Scientist, TNO (Netherlands Organisation for Applied Scientific Research)

Impact of AMS on Clinical Development: the Availability of Early Human ADME Data

Sheri Wilcox, PhD, Senior Director, Analytical and Discovery Sciences, SomaLogic Inc.

The SOMAscan® Assay and Pharmaceutical Development

Jingjing Yu, MD, PhD, Associate Director, University of Washington Drug Interaction Database Program

Mechanistic Analysis of Pharmacokinetic-Based Drug-Drug Interactions with Recently Marketed Drugs: from in vitro to Clinical Relevance

Li Yu, PhD, Pharmaceutical Sciences Site Head NY and DMPK/PD Leader, Roche 

Identification and Characterization of Metabolites from the Human ADME Study on Alectinib - Overcoming the Low Sensitivity of the Conventional LC-LSC Method for Plasma

Sue Zhu, PhD, Investigator II, PK Sciences, Novartis Institutes for Biomedical Research

Biopharmaceutics and Clinical Pharmacology Considerations for Tisagenlecleucel Development-The First FDA Approved CAR-T Cell Therapy

James Schiller, Dierector of GLP Reg. BA group at Merck

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guidline Internally and/or with Outsourcing Partners - Pharma Perspective

Jennifer Zimmer,PhD, Laboratory Dierector at Alturas Analytics

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners - CRP Perspective

Huidong (Ryan) Gu, PhD Senior Research Scientists, Bristol-Myers Squibb

In-Sample Calibration Curve Using Multiple Isotopologue Reaction Monitoring of a SIL-Analyte for LC-MS/MS Bioanalysis 

Ajit Suri,PhD, Senior Scientific Director, Takeda Pharmaceuticals

Derek Lowe, Director Chemical Biology Therapeutics at Novartis Institutes for BioMedical Research

Fortune Favors the Prepared Mind